Summary
ASKA Pharmaceutical Co., Ltd. (ASKA) is a pharmaceutical company that develops and markets pharmaceuticals, quasi-drugs, foods, medical devices and veterinary medicines. The company also imports and exports pharmaceuticals and medical devices. Its activities include production, drug information, and research and development activities. ASKA develops in-house original products with Altat and Prostal. The company markets its products through its network of distributors across the world. It partners with other pharma and medical device companies to market its products across various markets. ASKA is headquartered in Tokyo, Japan.
ASKA Pharmaceutical Co., Ltd. (4514) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
ASKA Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
ASKA Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
ASKA Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
ASKA Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
ASKA Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
ASKA Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Aska Pharma Enters Into Co-Marketing Agreement With Nihon Pharma For Minclea 10
Licensing Agreements 11
Takeda and Aska Pharma Enter into Licensing Agreement for Candesartan Aska 11
ASKA Pharma Enters Into Licensing Agreement With HRA Pharma For ellaOne 12
Astellas Pharma Enters Into Licensing Agreement With ASKA Pharma For AKP-002 13
ASKA Pharma Enters into Licensing Agreement with Alfa Wassermann 14
Acquisition 15
Aska Pharma Divests 40% Stake in Ceolia Pharma 15
ASKA Pharmaceutical Co., Ltd. - Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19
List of Tables
ASKA Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Key Facts, 2015 1
ASKA Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
ASKA Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
ASKA Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
ASKA Pharmaceutical Co., Ltd., Deals By Therapy Area, 2010 to YTD 2016 8
ASKA Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Aska Pharma Enters Into Co-Marketing Agreement With Nihon Pharma For Minclea 10
Takeda and Aska Pharma Enter into Licensing Agreement for Candesartan Aska 11
ASKA Pharma Enters Into Licensing Agreement With HRA Pharma For ellaOne 12
Astellas Pharma Enters Into Licensing Agreement With ASKA Pharma For AKP-002 13
ASKA Pharma Enters into Licensing Agreement with Alfa Wassermann 14
Aska Pharma Divests 40% Stake in Ceolia Pharma 15
ASKA Pharmaceutical Co., Ltd., Key Competitors 16
ASKA Pharmaceutical Co., Ltd., Key Employees 17
List of Figures
ASKA Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
ASKA Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
ASKA Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
ASKA Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
ASKA Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
ASKA Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
ASKA Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
ASKA Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8